NCT01638286
Completed
Not Applicable
Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects
Hanmi Pharmaceutical Company Limited0 sites24 target enrollmentAugust 2012
ConditionsAcute Low Back Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Low Back Pain
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
A randomized, open label, single-dose, 6-sequence, 3-period, crossover study to evaluate a pharmacokinetic drug interaction between eperisone hydrochloride and aceclofenac in healthy male subjects.
Investigators
Eligibility Criteria
Inclusion Criteria
- •BMI : 20.0 - 28.0 kg/m2 willingness to sign the written informed consent form(ICF)
Exclusion Criteria
- •Evidence of clinically relevant pathology within 30 days prior to drug administration History of relevant drug and/or food allergies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male SubjectsHealthyNCT02071381Daewon Pharmaceutical Co., Ltd.
Completed
Phase 1
A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy VolunteersHealthyNCT00901576Shire38
Unknown
Phase 1
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male AdultsHealthyNCT04343547Daewoong Pharmaceutical Co. LTD.34
Completed
Phase 1
Multiple Dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability of NDC-002 in Healthy VolunteersStroke SequelaeStrokeNCT06090474Dr. Noah Biotech Inc.33
Completed
Phase 1
A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and HydrochlorothiazideHealthyNCT03889145IlDong Pharmaceutical Co Ltd30